$0.170100
-0.0059-3.35%
At Close: -
$0.171900
0.00181.06%
After Hours: 6:16 PM EDT
15 minutes delayed
Aptevo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aptevo Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-1.67 | $-3.92 | 57.4 % |
Mar 2024 | 2024-05-08 | $-9.95 | $-12.84 | 22.5 % |
Dec 2023 | 2024-03-05 | $-1.76 | $-18.04 | 90.2 % |
Sep 2023 | 2023-11-14 | $-22.00 | $-33.00 | 33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2022 | 2022-08-11 | $0 | $3.42M | -100.0 % |
Mar 2022 | 2022-05-12 | $3.11M | $3.75M | -17.0 % |
Dec 2021 | 2022-03-24 | $3.67M | $3.40M | 7.79 % |
Sep 2021 | 2021-11-12 | $3.10M | $3.65M | -15.2 % |
Aptevo Therapeutics (APVO) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-1.67, which beat the estimate of $-3.92.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.